Heart Failure 2010 - Oct. 21-22, 2010, Cleveland, Ohio Heart Failure 2010 - Oct. 21-22, 2010, Cleveland, Ohio Heart Failure 2010 - Oct. 21-22, 2010, Cleveland, Ohio
event overview event faculty event agenda call for abstracts grantors and exhibitors about cleveland event registration hotel accommodations general information event brochure

Agenda

American Association for Thoracic Surgery (AATS)


 

 

  Thursday, October 21, 2010

7:55 am Welcome and Announcements
Session I: Contemporary Issues in Heart Failure Management
Moderators:  Randall C. Starling, MD, MPH and Nicholas G. Smedira, MD
8:00 am Quality and Outcomes Data in Heart Failure - Clyde W. Yancy, MD
8:20 am Expanding Indications for CRT: Putting MADIT-CRT into the Context of Heart Failure Practice - Bruce D. Lindsay, MD
8:40 am Risk Stratification in Heart Failure Using Novel Imaging Techniques - Thomas Marwick, MD, PhD
9:00 am The Evolution of MCS over the Past 30 Years - O. Howard Frazier, MD
9:20 am Are We Ready for LVADS in Class III Patients? - Joseph G. Rogers, MD
9:40 - 10:00 am Panel Discussion
10:00 - 10:30 am Break
Session II: Contemporary Issues in Heart Failure Management
Moderators:  Christine S. Moravec, PhD and Robert Hobbs, MD
10:30 am Registries and Guidelines: Have They Helped Us Provide Better Patient Care in the Real World? - Eiran Gorodeski, MD, MPH
10:50 am Addressing Anemia in Heart Failure: What Have We Learned? - W. H. Wilson Tang, MD
11:10 am New Insights into the Cardiorenal Syndrome - Maria Rosa Costanzo, MD
11:30 am Vasodilators in the Setting of ADHF - John R. Teerlink, MD         
11:50 - 12:10 pm Panel Discussion
12:10 - 1:15 pm Lunch
Session III: Kaufman Center Award and Lecture
Introduced by Randall C. Starling, MD, MPH
1:15 pm James B. Young, MD
Session IV: Clinical Trials of Drugs and Devices for Heart Failure
Moderator:  James B. Young, MD
1:45 pm Will Clinical Site Research Survive in the U.S. and Can We Afford It? - Robert M. Califf, MD
2:05 pm The STICH Trial: What Went Wrong, What Went Right? - John V. Conte, MD
2:25 pm Are the Patients We Study Those We Treat? - Clyde W. Yancy, MD
2:45 pm The Economics of Developing New Drugs and Devices: Is the Pipeline for New Drugs “Drying Up”? - Steven Nissen, MD
3:05 pm LVAD: Regulatory Issues Ileana - Ileana L. Piňa, MD, MPH
3:25 - 3:45 pm Panel Discussion
Session V: Update on the Medical and Surgical Management of Ischemic Cardiomyopathy
Moderator:  Soon J. Park, MD
3:45 pm State of the Art Cardiac Regeneration with Stem Cells - Marc S. Penn, MD, PhD
4:05 pm Ventricular Reconstruction: Indications, Physiologic Impact, Surgical Techniques, and Outcomes - Robert A.E. Dion, MD
4:25 pm The Treatment of Ischemic Mitral Valve Disease:
 
Imaging - Robert A. Levine, MD
Repair - Tomislav Mihaljevic, MD
5:00 pm Panel Discussion
5:30 pm Poster Presentations / Attendee Reception / Exhibits
Back To Top

  Friday, October 22, 2010

Session VI: Mechanical Circulatory Support and Transplant: Patient Selection
Moderators:  David O. Taylor, MD and Nicholas G. Smedira, MD
8:00 am Where is the Data That Obesity is a Contraindication to Heart Transplant and MCS? - David O. Taylor, MD
8:20 am Gastric Bypass Surgery for Heart Failure: The Impact of Weight Loss on CV Structure and Function - Philip R. Schauer, MD
8:40 am Strategies for LVAD Therapy: Does BTT, BTC and DT Impact Management and Outcomes? - Benjamin C. Sun, MD
9:00 am Pre-Operative Predictors of Post LVAD Mortality - Leslie W. Miller, MD
9:20 am A Good LVAD is Better Than a Bad Transplant! - George M. Wieselthaler, MD
9:40 - 10:00 am  Panel Discussion
10:00 - 10:20 am Break
Session VII: Management of the Patient on MCS in the Continuum of Care
Moderator:  Nicholas G. Smedira, MD and George M. Wieselthaler, MD
10:20 am Management of Acute Decompensated Heart Failure and Shock (Point/Counterpoint)
 
Back to the Future:  ECMO Should be the First Choice - Pascal N. Leprince MD, PhD
Avoid an Oxygenator At All Costs: Tandem Heart or Impella - Edward Soltesz, MD
10:50 am Managing RV Failure (Point/Counterpoint)
 
Temporary RV Support is the Best Strategy - Leslie W. Miller, MD
Early Planned BiV Support Results in Improved Outcomes - Michael A. Acker, MD
11:20 am Eliminate Drive-Line Infection - Nicholas G. Smedira, MD
11:35 am Neurological Events: Patient? Device? Management? - Maria Mountis, DO
11:50 am Are ICDs Beneficial in the LVAD Population - Daniel J. Cantillon, MD
12:05 pm Outpatient Management of the “Destination” Patient: Are Focused Clinics and Telemanagement the Answer? - Robert L. Kormos, MD
12:20 pm Utilizing Best Practices to Reduce Readmissions in the LVAD Population - Laura D. Damme, RN, MPH
12:35 - 12:55 pm Panel Discussion
12:45 pm Lunch
Session VIII: The Present and Future of Innovation in MCS
Moderator:  Robert L. Kormos, MD
2:00 pm Total Artificial Heart
 
Why I Love It - Jack G. Copeland, MD
Why I Hate It - Gonzalo Gonzalez-Stawinski, MD
2:40 pm Update on New Technology:  Duraheart, Terumo, and Heartware - Aly El-Banayosy, MD
3:00 pm Update on New Technology: Tandem Heart, Impella, Circulite - William E. Cohn, MD
3:20 pm Maximizing Reimbursement for Innovation - Robin Roberts Bostic
3:40 pm Will MCS Replace Heart Transplant in this Decade? - Leonard Golding, MD
4:00 - 4:20 pm Panel Discussion
  Adjourn
Back To Top

 

 
Bookmark this Chapter
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195